Cite
HARVARD Citation
Harada, N. et al. (2014). Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin. Journal of viral hepatitis. 21 (5), pp. 357-365. [Online].